Free Trial

Evercore ISI Forecasts Strong Price Appreciation for Intuitive Surgical (NASDAQ:ISRG) Stock

Intuitive Surgical logo with Medical background

Intuitive Surgical (NASDAQ:ISRG - Free Report) had its price objective upped by Evercore ISI from $490.00 to $530.00 in a report published on Monday morning.

Other equities research analysts have also recently issued reports about the company. UBS Group lifted their price objective on Intuitive Surgical from $500.00 to $560.00 and gave the company a "neutral" rating in a research note on Monday. Oppenheimer reiterated a "market perform" rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Raymond James increased their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an "outperform" rating in a research report on Friday. JPMorgan Chase & Co. lifted their price objective on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an "overweight" rating in a report on Friday. Finally, Stifel Nicolaus increased their target price on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a "buy" rating in a report on Thursday, December 5th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have given a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $613.10.

Check Out Our Latest Report on Intuitive Surgical

Intuitive Surgical Trading Down 1.8 %

Intuitive Surgical stock traded down $10.57 during trading on Monday, hitting $573.48. The company had a trading volume of 2,439,723 shares, compared to its average volume of 2,025,429. The stock has a market cap of $204.26 billion, a price-to-earnings ratio of 92.20, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39. Intuitive Surgical has a 1-year low of $364.17 and a 1-year high of $616.00. The company's 50 day simple moving average is $547.16 and its 200-day simple moving average is $505.21.

Insiders Place Their Bets

In other news, CFO Jamie Samath sold 270 shares of the business's stock in a transaction dated Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total transaction of $145,840.50. Following the completion of the sale, the chief financial officer now owns 8,757 shares in the company, valued at approximately $4,730,093.55. The trade was a 2.99 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Robert Desantis sold 188 shares of the firm's stock in a transaction that occurred on Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total transaction of $95,225.76. Following the completion of the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,788,899.12. The trade was a 3.30 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 42,453 shares of company stock valued at $22,059,506 over the last quarter. Company insiders own 0.90% of the company's stock.

Institutional Trading of Intuitive Surgical

Large investors have recently added to or reduced their stakes in the stock. State Street Corp grew its stake in shares of Intuitive Surgical by 1.4% in the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider's stock valued at $7,393,673,000 after buying an additional 210,363 shares in the last quarter. FMR LLC boosted its holdings in Intuitive Surgical by 8.3% in the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider's stock worth $5,389,765,000 after acquiring an additional 838,793 shares during the period. Geode Capital Management LLC grew its position in Intuitive Surgical by 1.9% in the third quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider's stock valued at $3,677,194,000 after acquiring an additional 143,440 shares in the last quarter. Fisher Asset Management LLC raised its stake in shares of Intuitive Surgical by 1.8% during the third quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider's stock valued at $2,349,441,000 after purchasing an additional 86,208 shares during the period. Finally, Baillie Gifford & Co. lifted its position in shares of Intuitive Surgical by 0.6% during the third quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider's stock worth $1,890,676,000 after purchasing an additional 24,183 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Company Profile

(Get Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Read More

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Should You Invest $1,000 in Intuitive Surgical Right Now?

Before you consider Intuitive Surgical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.

While Intuitive Surgical currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 AI Bargain Stocks to BUY NOW After the DeepSeek Crash
NVIDIA Stock Under Pressure: DeepSeek and the AI Tech War
Nuclear Energy’s Comeback: 7 Stocks to Watch in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines